|
The
Benefits of Studying Medicinal Plants and
Ethnobotany
(page 7)
by
Kimberly
Johnson, MD
Every
future human activity that utilizes biological resources depends on
our stewardship of biodiversity today.
Medicinal
Plants: Much to Win, Much to Lose
No subset of
biodiversity is so closely linked to humankind's past and future as
the plant kingdom, which provides our food supply and also furnishes
oils, latexes, gums, fibers, timbers, dyes, and other products we use
to clean, clothe, shelter, and refresh ourselves. Healthy assemblages
of native plants renew and enrich soils, regulate our freshwater supplies,
prevent soil erosion, and provide the habitat needed by animals and
other creatures (Tuxill 1999). Large plant
assemblages also provide a rich hunting ground for new medical compounds.
If we protect and learn about the intricacies of intact ecosystems,
we have a great deal to win... and if we fail to do this, we have a
great deal to lose.
Fewer than 1-2%
of the world's 250,000 flowering plant species have been analyzed for
medicinal value. Evolution has created ingenious chemicals not conceived
of by humans. Hidden within the plant kingdom are the secrets of hundreds
of millions of years of natural adaptation and hundreds of billions
of biological experiments that, due to the threat of extinction, are
in danger of being forever lost to medical science.
Plants have
formed the foundation of the pharmacopoeia of traditional systems of
medicine for millennia, and continue to be critically important today.
In a study published in 1985, 25% of physician-prescribed pharmaceuticals
currently in use contained active ingredients derived from plants (Farnsworth
1985).
The perceived
monetary value of the natural resources of local and indigenous peoples
throughout the world threatens their natural environments and cultures.
It is vital that we realize the potential economic value of saving habitats
and indigenous cultures, which far outweighs the lands' value for commercial
farming, ranching, timber, or mining. When one argues to preserve biodiversity,
one is also arguing to preserve ecosystems. While it is clear that the
pharmaceutical value of an ecosystem's plants represents only one component,
it is easier to quantify than other ecosystem services (such as clean
water or air for human consumption). Thus, the pharmacological properties
of plants provides an important indicator of the value of biodiversity.
Sales
of plant-based drugs in the US alone were estimated at $15.5 billion
in 1990.
The market value
of plant-based prescriptions filled in the U.S. in 1980 was estimated
to exceed $8 billion (Farnsworth and Soejarto
1985). A more recent estimated market value of total U.S. sales
of plant-based pharmaceuticals at 1990 retail prices was $15.5 billion!
| 
References
on this page:
Balick,
M.J., E. Elisabetsky, and S. Laird, eds. 1996. Medicinal Resources
of the Tropical Forest: Biodiversity and its Importance to Human Health.
New York: Columbia University Press.
Articles by authors
in the above text:
- Principe, P.
"Monetizing the pharmacological benefits of plants." Pp
191-218.
- Tyler, V. "Natural
products and medicine: an overview." Pp 3-10.
Tuxill,
J. 1999. Nature's Cornucopia: Our Stake in Plant Diversity. Worldwatch
Paper 148. Worldwatch Institute, Washington DC.
Farnsworth,
N.R. and D.D. Soejarto. 1985. "Potential consequence of plant extinction
in the United States on the current and future availability of prescription
drugs." Economic Botany. 39 (3):231-40.
Farnsworth,
N.R. et al. 1985. "Medicinal plants in therapy." Bulletin
of the World Health Organization. 63 (6): 965-81.